Research Scope: Nanomaterial Migration from Consumer Products

ALETHEIA Safety Reference Database

Core Research Question

Do nanoparticle coatings (nano-hydroxyapatite, nanoclay, nano-platinum) migrate at levels of concern from consumer products?

1

Research Question

The ALETHEIA database flags 3 nanomaterials with no_substitute_reason: "emerging_nanomaterial" plus a 4th (nano-TiO₂) as borderline. These are in consumer products (toothpaste, food packaging, cosmetics, catalytic converters). The critical question: do nanoparticles migrate from their product matrix into the body at toxicologically relevant doses? Product-bound nanoparticles may have completely different risk profiles than free nanoparticles.

This research scope addresses a fundamental gap in the safety assessment framework: the distinction between nanomaterial presence in a formulation and actual human exposure. Understanding migration mechanisms and rates is essential for updating the ALETHEIA database with exposure-informed risk classifications.

2

Scope & Compounds

Nanomaterial Primary Product Use Matrix Migration Concern DB Status
Nano-hydroxyapatite (n-HAp) Toothpaste, dental products Aqueous paste Oral mucosa absorption, ingestion no_substitute, emerging
Nanoclay (montmorillonite) Food packaging barrier layers Polymer composite Food contact migration no_substitute, emerging
Nano-platinum (Pt NPs) Catalytic converters, cosmetics Ceramic/cream matrix Inhalation (exhaust), dermal no_substitute, emerging
Nano-TiO₂ Sunscreen, food additive (E171) Cream/powder dispersion Dermal penetration, ingestion MODERATE risk, alternatives exist
Nano-SiO₂ Food additive (E551), cosmetics Powder/dispersion Ingestion, inhalation LOW-MOD, widely used
Nano-ZnO Sunscreen Cream matrix Dermal penetration MODERATE, alt. to chemical UV
3

Evidence Framework

Migration Testing

EU 10/2011 food contact migration tests; FDA extractables/leachables framework; ISO 10993 biocompatibility for dental/medical. How much nanoparticle actually leaves the product matrix under realistic use conditions?

Exposure Reconstruction

Combine migration rates with product use patterns (frequency, duration, amount) to estimate daily nanoparticle intake by route (oral, dermal, inhalation). Compare to NOAEL/DNEL values where available.

Nano-Specific Toxicology

Size-dependent cellular uptake, protein corona effects, lysosomal disruption, genotoxicity at nano-scale. Key question: do established bulk-material safety assessments apply, or does nano-form require separate evaluation?

4

Methodology

  • Migration modeling: Fick's law diffusion modeling for polymer-bound nanoparticles (nanoclay in PET, LDPE); partition coefficient estimation
  • In-vitro release testing: Literature compilation of dissolution/release rates for n-HAp in artificial saliva, nano-TiO₂ in artificial sweat, nanoclay in food simulants (10% ethanol, 3% acetic acid, olive oil)
  • Exposure assessment: Probabilistic Monte Carlo exposure modeling using ConsExpo/RIVM framework for dermal, oral, and inhalation routes
  • Hazard quotient: Compare estimated exposure to DNEL (derived no-effect level) or TTC (threshold of toxicological concern) for nanomaterials
  • Regulatory landscape: EU Novel Food regulation for n-HAp, EFSA 2021 TiO₂ opinion (E171 ban), SCCS opinions on nano-ZnO/TiO₂ in sunscreen
5

Expected Outcomes

Deliverables

Migration rate estimates (μg/cm²/day or μg/kg food) for each nanomaterial-product pair

Exposure margins for realistic consumer use scenarios

Decision framework: When does "nano in product" ≠ "nano exposure"?

DB update: Add migration_assessment object to nanomaterial compounds with matrix_bound: true/false, estimated_migration_rate, exposure_margin

6

Timeline

Phase 1

Literature
2 weeks — migration data compilation, 40–80 papers

Phase 2

Modeling
3 weeks — diffusion modeling + Monte Carlo exposure

Phase 3

Hazard
1 week — hazard quotient calculations

Phase 4

DB Update
1 week — implement across nanomaterial entries + decision framework

Total: ~7 weeks

7

Key References

  • EFSA (2021) "Safety assessment of titanium dioxide (E171) as a food additive" EFSA Journal 19(5):e06585 — the opinion concluding E171 can no longer be considered safe (PMID 33976718) · archived
  • SCCS (2012) "Opinion on Zinc Oxide (nano form)" SCCS/1489/12 (the foundational nano-ZnO UV-filter opinion + Addendum SCCS/1518/13)
  • Bott et al. (2014) "Migration of nanoparticles from plastic packaging materials containing carbon black into foodstuffs" Food Additives & Contaminants Part A 31(10):1769–82 (PMID 25105506)
  • Echegoyen & Nerín (2013) "Nanoparticle release from nano-silver antimicrobial food containers" Food and Chemical Toxicology 62:16–22 (PMID 23954768)
  • SCCS — Hydroxyapatite (nano) "Opinion on Hydroxyapatite (nano)" Scientific Committee on Consumer Safety (the authoritative nano-hydroxyapatite oral-care safety opinion)
  • OECD "Testing Programme of Manufactured Nanomaterials" (WPMN) — ongoing programme (no single resolvable progress-report URL confirmed)
  • Oberdörster et al. (2005) "Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles" Environmental Health Perspectives 113(7):823–39 (PMID 16002369) · archived
  • Nel et al. (2006) "Toxic Potential of Materials at the Nanolevel" Science 311(5761):622–7 (PMID 16456071) · archived
6
Nanomaterials in DB
1–100
Particle Range (nm)
7
Timeline (weeks)
MODERATE
Priority Level